Biosurface Technologies Inc
Biosurface Technologies Inc. (BioSET) is a development stage medical technology company engaged in the development of synthetic growth factors which mimic the effect of naturally occurring growth factors, but which are much less expensive to produce and easier to incorporate into coatings for medical devices. The company has completed successful clinical trials in Canada evaluating a BMP-2 mimetic (B2A) product for both spine and ankle fusions. The FDA has approved a pivotal clinical trial for a